Ultragenyx Pharmaceutical RARE Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Ultragenyx Pharmaceutical’s reported figures.
Based on trailing twelve months.
The official record: Ultragenyx Pharmaceutical’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ultragenyx Pharmaceutical's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ultragenyx Pharmaceutical's asset turnover?
- Ultragenyx Pharmaceutical (RARE) reported asset turnover of 0.5× in Q1 2026.
- How has Ultragenyx Pharmaceutical's asset turnover changed year-over-year?
- Ultragenyx Pharmaceutical's asset turnover increased by 14.0% year-over-year, from 0.5× to 0.5×.
- What is the long-term trend for Ultragenyx Pharmaceutical's asset turnover?
- Over 5 years (2020 to 2025), Ultragenyx Pharmaceutical's asset turnover has grown at a 18.8% compound annual growth rate (CAGR), from 0.2× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.